Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home AI & Quantum Computing

ServiceNow Shares Surge as Artificial Intelligence Drives Record Performance

Robert Sasse by Robert Sasse
November 3, 2025
in AI & Quantum Computing, Earnings, Nasdaq, Tech & Software
0
ServiceNow Stock
0
SHARES
16
VIEWS
Share on FacebookShare on Twitter

ServiceNow is demonstrating that artificial intelligence represents far more than temporary market excitement—it’s already generating billions in measurable revenue. The enterprise software leader delivered a powerful statement to investors through exceptional quarterly results and a proposed stock split, though questions remain about whether its AI advantage can sustain long-term momentum.

Strategic Partnerships and Stock Split Enhance Market Position

Beyond its operational achievements, ServiceNow is making strategic moves to strengthen its market position. The company’s board has approved a 5-for-1 stock split, with shareholder voting scheduled for December 5. This initiative aims to make the equity more accessible to a broader investor base.

Concurrently, ServiceNow has expanded its collaboration with NVIDIA and introduced Apriel 2.0, an advanced AI model featuring multimodal capabilities. The newly launched “AI Experience” interface and “Zurich Platform” are designed to accelerate AI implementation and enable autonomous workflow solutions.

Quarterly Performance Exceeds Expectations

Investors responded enthusiastically to third-quarter 2025 results that surpassed all projections. ServiceNow reported adjusted earnings of $4.82 per share, significantly higher than the $4.26 consensus estimate. Revenue climbed 22% to reach $3.41 billion, while current remaining performance obligations—representing contracted future revenue—expanded 21% to $11.35 billion.

Should investors sell immediately? Or is it worth buying ServiceNow?

Chief Executive Officer Bill McDermott emphasized AI’s central role in the company’s trajectory: “We are the AI platform for business transformation.” The organization’s internal AI initiatives have already produced $355 million, which has been reinvested into operations. Management is targeting AI-related revenue to reach the billion-dollar threshold by 2026.

Analyst Community Reinforces Bullish Outlook

Market analysts uniformly expressed confidence in ServiceNow’s prospects. Wells Fargo raised its price target to $1,275, while TD Cowen increased its objective to $1,250. Research firms including RBC Capital, Piper Sandler, and Wolfe Research reaffirmed their “Outperform” and “Overweight” ratings, citing extensive AI opportunities and robust demand from federal government clients.

Chief Financial Officer Gina Mastantuono noted that AI adoption has become standard in sales processes, revealing that “since May, we’ve observed 55-fold growth in AI assistance.” She did acknowledge potential headwinds, citing cautious spending patterns due to the ongoing government shutdown that could delay procurement timelines.

The critical question remains whether ServiceNow can convert its AI leadership into sustained expansion. With the foundation firmly established, the coming quarters will determine if the company can deliver on its substantial growth expectations.

Ad

ServiceNow Stock: Buy or Sell?! New ServiceNow Analysis from March 25 delivers the answer:

The latest ServiceNow figures speak for themselves: Urgent action needed for ServiceNow investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.

ServiceNow: Buy or sell? Read more here...

Tags: ServiceNow
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

SOXX ETF Stock
Commodities

Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns

March 25, 2026
Fair Isaac Stock
Analysis

Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

March 25, 2026
Figma Stock
AI & Quantum Computing

Figma Embraces Third-Party AI to Power Its Design Ecosystem

March 25, 2026
Next Post
Texas Instruments Stock

Can Texas Instruments Overcome Technical Headwinds?

Snowflake Stock

Snowflake Faces Investor Confidence Test After Executive's Rogue Forecast

Semler Scientific Stock

Semler Scientific Faces Critical Juncture Amid Acquisition and Bitcoin Strategy

Recommended

Lockheed Martin Stock

Defense Giant Lockheed Martin Secures Billions in New Military Contracts

6 months ago
OKE stock news

Amalgamated Bank Increases Stake in CF Industries as Market Opinions Vary

3 years ago
IBM Stock

IBM’s AI Windfall Fails to Impress Stock Market

7 months ago
Blackstonecured Lending Fund Stock

Blackstone BDC Insider Purchase Defies Analyst Downgrades

4 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Figma Embraces Third-Party AI to Power Its Design Ecosystem

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

Evolent Health Bets on AI Leadership Amid Share Price Decline

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

Trending

Gossamer Bio Stock
Analysis

Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026

by Kennethcix
March 25, 2026
0

The future of Gossamer Bio hinges on a critical regulatory discussion scheduled for June 2026. The biopharmaceutical...

SOXX ETF Stock

Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns

March 25, 2026
Fair Isaac Stock

Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

March 25, 2026
Figma Stock

Figma Embraces Third-Party AI to Power Its Design Ecosystem

March 25, 2026
BioNano Genomics Stock

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026
  • Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns
  • Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com